Literature DB >> 12711630

Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.

Michung Yoon1, Hyunghee Lee, Sunhyo Jeong, Jung-Jae Kim, Christopher J Nicol, Kung Woo Nam, Moonza Kim, Byung Goo Cho, Goo Taeg Oh.   

Abstract

1. Peroxisome proliferator-activated receptor alpha (PPARalpha) regulates the expression of the key genes involved in lipid metabolism following activation of this receptor by various ligands. Ginseng, a highly valuable medicine in oriental societies, is also reported to modulate lipid metabolism, although the mechanism of its action remains unknown. In order to test our hypothesis that ginseng exerts its effects by altering PPARalpha-mediated pathways, the effects of Korean red ginseng on PPARalpha function and serum lipid profiles were investigated using in vivo and in vitro approaches. 2. In vivo administration of ginseng extract (GE) and ginsenosides (GS) not only inhibited mRNA levels of acyl-CoA oxidase, a rate-limiting enzyme for PPARalpha-mediated peroxisomal fatty acid beta-oxidation, induced by the potent PPARalpha ligand Wy14,643 in a dose- and time-dependent manner, but also inhibited the induction of PPARalpha target genes expected following treatment with Wy14,643. 3. Consistent with the in vivo data, both GE and GS caused dose-dependent decreases in the endogenous expression of a luciferase reporter gene containing the PPAR responsive element (PPRE), while GS significantly decreased the magnitude of reporter gene activation in the presence of Wy14,643. 4. Serological studies demonstrated that, compared with vehicle-treated mice, treatment with GS significantly increased serum concentrations of total cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol. Compared to groups treated with Wy14,643 alone, which significantly decreased serum triglyceride and HDL cholesterol levels versus controls, coadministration of either GE or GS with Wy14,643 modestly increased serum triglycerides and HDL cholesterol. 5. These results indicate that the effects of ginseng on serum lipid profiles may be mediated by changes in the expression of PPARalpha target genes, providing the first evidence that in vivo and in vitro treatments of ginseng modulate PPARalpha action. In addition, these data suggest that ginseng can act as an inhibitor of PPARalpha function, which may have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711630      PMCID: PMC1573779          DOI: 10.1038/sj.bjp.0705169

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.

Authors:  Y K Lee; H Dell; D H Dowhan; M Hadzopoulou-Cladaras; D D Moore
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Ginseng pharmacology: multiple constituents and multiple actions.

Authors:  A S Attele; J A Wu; C S Yuan
Journal:  Biochem Pharmacol       Date:  1999-12-01       Impact factor: 5.858

3.  Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals.

Authors:  M Inoue; C Z Wu; D Q Dou; Y J Chen; Y Ogihara
Journal:  Phytomedicine       Date:  1999-10       Impact factor: 5.340

4.  Study of the hypolipidemic properties of pectin, garlic and ginseng in hypercholesterolemic rabbits.

Authors:  M F Ismail; M Z Gad; M A Hamdy
Journal:  Pharmacol Res       Date:  1999-02       Impact factor: 7.658

5.  Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids.

Authors:  C J Sinal; M Yoon; F J Gonzalez
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

6.  Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis.

Authors:  P Costet; C Legendre; J Moré; A Edgar; P Galtier; T Pineau
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

7.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

8.  Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).

Authors:  W Seol; B Hanstein; M Brown; D D Moore
Journal:  Mol Endocrinol       Date:  1998-10

9.  Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes.

Authors:  D L Kroetz; P Yook; P Costet; P Bianchi; T Pineau
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  Orally administered ginseng extract reduces serum total cholesterol and triglycerides that induce fatty liver in 66% hepatectomized rats.

Authors:  X Cui; T Sakaguchi; D Ishizuka; K Tsukada; K Hatakeyama
Journal:  J Int Med Res       Date:  1998 Aug-Sep       Impact factor: 1.671

View more
  16 in total

1.  Effects of Korean white ginseng extracts on obesity in high-fat diet-induced obese mice.

Authors:  Young-Sil Lee; Byung-Yoon Cha; Kohji Yamaguchi; Sun-Sil Choi; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo
Journal:  Cytotechnology       Date:  2010-09-23       Impact factor: 2.058

Review 2.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 3.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

4.  The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type 2 diabetes.

Authors:  Hai-xiang Ni; Ning-juan Yu; Xue-hui Yang
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

5.  Lipid-regulating effect of traditional chinese medicine: mechanisms of actions.

Authors:  Wei-Jian Bei; Jiao Guo; Hai-Yun Wu; Yang Cao
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

6.  Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs.

Authors:  Zhijun Wang; Jeffrey Wang; Patrick Chan
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-07       Impact factor: 2.629

7.  Ginseng and Its Active Components Ginsenosides Inhibit Adipogenesis in 3T3-L1 Cells by Regulating MMP-2 and MMP-9.

Authors:  Jaeho Oh; Hyunghee Lee; Dongmin Park; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

Review 8.  Protective effects of ginseng on neurological disorders.

Authors:  Wei-Yi Ong; Tahira Farooqui; Hwee-Ling Koh; Akhlaq A Farooqui; Eng-Ang Ling
Journal:  Front Aging Neurosci       Date:  2015-07-16       Impact factor: 5.750

9.  Ginsenoside-Rb1 Induces ARPE-19 Proliferation and Reduces VEGF Release.

Authors:  Brandi S Betts; Kalpana Parvathaneni; Bharat B Yendluri; Jeffery Grigsby; Andrew T C Tsin
Journal:  ISRN Ophthalmol       Date:  2012-01-04

10.  Effects of ethanolic extract of green tea on decreasing the level of lipid profile in rat.

Authors:  Farjad Amanolahi; Hasan Rakhshande
Journal:  Avicenna J Phytomed       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.